WHO ICTRP trial
The study of the new regimen of the AZT administration to the neonate for…
JPRN-UMIN000008935 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000008935 |
|---|---|
| Public title | The study of the new regimen of the AZT administration to the neonate for preventing HIV mother-to-child transmission |
| Scientific title | The study of the new regimen of the AZT administration to the neonate for preventing HIV mother-to-child transmission - Comparative analysis of the effectiveness and safety between two regimens; AZT 2mg/kg four times a day for 6 weeks (previous regimen) and AZT 4mg/kg twice a day for 6 weeks (new… |
| Primary sponsor | National Center for Global Health and Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | HIV |
| Interventions | The neonates are given 4mg/kg of AZT twice a day for 6 weeks orally/intravenously Extension criteria The neonates who receive HIV or suspected HIV infection |
| Registration date | Sep 17, 2012 |
| Target size | 12 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: